Literature DB >> 12667108

Anti-epileptic drugs in pregnancy: current safety and other issues.

James I Morrow1, John J Craig.   

Abstract

Women with epilepsy of child-bearing years have their own considerations, which must be taken into account if management of their epilepsy is to be optimised. The main issues to consider include the effects of: female hormones on seizure control, anti-epileptic drugs (AEDs) on hormonal methods of contraception, epilepsy and AEDs on fertility, epilepsy and AEDs on pregnancy itself, pregnancy on AEDs and seizure control and epilepsy, seizures and AEDs on the developing embryo/fetus. Whereas previous studies have concentrated on the increased risk of major congenital malformations from prenatal AED exposure, the effects on cognitive and behavioural development are increasingly being explored. This article looks at the evidence currently available for all of the above issues, taking into account the increased number of AEDs which are now available.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667108     DOI: 10.1517/14656566.4.4.445

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Authors:  J Morrow; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; R C McGivern; P J Morrison; J Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-12       Impact factor: 10.154

Review 2.  Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?

Authors:  Naghme Adab
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Effect of anti-epileptic drugs in pregnancy and teratogenesis.

Authors:  Sowbhagya Lakshmi; Kulkarni Sunanda
Journal:  Indian J Clin Biochem       Date:  2008-10-01

4.  The course and outcome of pregnancy and neonatal situation in epileptic women.

Authors:  Mohammad Reza Najafi; Farnoosh Sonbolestan; Seyed Ali Sonbolestan; Mohammad Zare; Jafar Mehvari; Shahrokh Noori Meshkati
Journal:  Adv Biomed Res       Date:  2012-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.